Klebsiella pneumoniae vaccine development webinar banner
Klebsiella pneumoniae Vaccine Development: Discovery to Clinic
Oct. 15, 2026 10:00 AM EDT I 3:00 PM BST
Register
Events
Meet BOC Sciences at AAPS PharmSci 360 2026 — Booth #811
Oct. 25–28, 2026, New Orleans, LA
Register
High-Throughput Screening

High-Throughput Screening

High-throughput screening (HTS) allows researchers to perform millions of biological, chemical, genetic, or pharmacological tests in a short time. It is mainly used in the drug discovery process to identify biologically relevant compounds. HTS is a useful tool for evaluating, for example, pharmacological targets, pharmacological profiling, and receptor antagonists (such as GPCRs) and enzymes.

Introduction of High-Throughput Screening

High-throughput screening is based on experimental approaches at the molecular and cellular levels. It takes the microplate as the experimental tool carrier, then performs the test process with an automated operating system. Experimental data is automatically collected with sensitive and fast detection instruments. HTS can test tens of millions of samples at the same time and get the corresponding database to support the operation of the technical system. HTS technology provides more rapid, sensitive, and accurate tools compared with conventional method.

Classification of High-Throughput Screening

1. According to different experimental models

2. According to different screening strategies

High throughput screening process

Application

References

  1. Hertzberg RP; et al. High-throughput screening: new technology for the 21st century. Curr Opin Chem Biol. 2000 Aug; 4(4): 445-51.
  2. Mayr L M; et al. The future of high-throughput screening. SLAS Discovery. 2008, 13(6): 443-448.
  3. Wildey M.J.; et al. High-throughput screening. Annual Reports in Medicinal Chemistry. 2017, 50, pp.149-195.

Online Inquiry

Verification code